MedPath

Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma

Conditions
Lung Adenocarcinoma
Registration Number
NCT01249066
Lead Sponsor
China Medical University Hospital
Brief Summary

AMP-activated protein kinase (AMPK) is an evolutionally conserved protein kinase that serves as an energy guardian to help cells adapt to various metabolic stress including hypoxia. Because the role of AMPK in cancers has not been fully elucidated, in this study we investigated the expression and activation of AMPK in lung adenocarcinoma (LADC) cells and tissue.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Lung cancer received operation lobectomy in CMUH
Read More
Exclusion Criteria
  • History of uremia, other malignant disease, and liver cirrhosis
  • History of pneumonia and pulmonary tuberculosis
  • History of long period of medications.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fang Hsin Yuan

🇨🇳

Taichung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath